A functional enzymatic assay as potential readout for a clinical trial of a schistosomiasis vaccine
Desalegn W. Kifle(Texas Tech University), Afzal A. Siddiqui(Texas Tech University), Birkneh Tilahun Tadesse(Hawassa University), Florian Marks(International Vaccine Institute), Yasuko Ono(Tokyo Metropolitan Institute of Medical Science), Lisa A. Jackson(Kaiser Permanente Washington Health Research Institute), Aravindan Kalyanasundaram(Texas Tech University), Bart L. Staker(Center for Infectious Disease Research), Jenn Davis(PAI Life Sciences (United States)), Darrick Carter(Infectious Disease Research Institute), Sean A. Gray(PAI Life Sciences (United States)), Jiho Kim(PAI Life Sciences (United States)), Justin K. Craig(Center for Infectious Disease Research), Aryandra Arya(Texas Tech University), Naoko Doi(Tokushima Municipal Hospital), Raphaël Rakotozandrindrainy(University of Antananarivo), Mumtaz Yaseen Balkhi(International Centre for Genetic Engineering and Biotechnology)
Cited by 3
Related Papers
The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017
|The Lancet Infectious Diseases|2019|852
The mechanism of topoisomerase I poisoning by a camptothecin analog
|Proceedings of the National Academy of Sciences|2002|800
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
|New England Journal of Medicine|2021|661